The KRT14 gene gives skin cells instructions to make keratin 14, a sturdy support protein that helps the outer skin layer stay strong during everyday rubbing and pressure. This gene helps your body build a stable framework inside skin cells. If you carry a disease-causing variant in the KRT14 gene, the skin can become fragile and blister easily after minor friction, and some people also have nail, mouth, or skin color changes. These variants are a known cause of some forms of epidermolysis bullosa simplex.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing activities in the body. Some genes carry the code for proteins, which do the work inside cells. Others mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
KRT14Gene function
What if the gene works
The KRT14 gene helps make keratin 14, a protein that supports the skin’s lower layer. Working with keratin 5, it helps skin cells resist everyday rubbing and pressure.
Risk
What if the gene does not work
Variants in the KRT14 gene most often weaken skin, causing blistering after minor friction (epidermolysis bullosa simplex). Milder and more severe variants can change when this starts and whether pigment, sweat, nail, or palm and sole changes appear.
Treatment
What does that mean for your treatment
For pathogenic variants in the KRT14 gene, no KRT14-specific treatment or drug choice is currently established. Care is supportive and usually centers on skin protection, wound care, pain relief, and lowering infection risk. The KRT14 gene is also being studied as a target for experimental RNA and gene-based therapies in some forms of epidermolysis bullosa simplex.
Conditions associated with KRT14
Gene function
What if the gene works
In the deepest part of the outer skin layer, the KRT14 gene helps cells stay strong during daily rubbing and pressure. It provides instructions for making keratin 14, a sturdy protein that forms internal support fibers with keratin 5. Understanding KRT14 gene function in skin cells helps explain how the skin keeps its shape while constantly renewing itself.
The KRT14 gene helps make a tough inner framework in skin cells that sit at the bottom of the outer skin layer. This framework lets skin bend, stretch, and handle friction from everyday movement.
Keratin 14 joins with keratin 5 to build long support fibers inside these cells. Together, they act like flexible cables that help each cell keep its shape.
These support fibers connect the cell interior to attachment points that help hold the lower skin layer in place. This gives the skin a steady base while surface cells are continuously replaced.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KRT14 gene can alter the keratin 14 protein so it is misshaped, less stable, or made in lower amounts, which weakens the support fibers inside skin cells. In this way, KRT14 gene variants affect function by making those fibers assemble poorly or break more easily when skin is rubbed. Milder variants may leave some protein activity, while more disruptive variants can strongly interfere with fiber formation or sharply reduce protein production, often linking to earlier or more widespread epidermolysis bullosa simplex.
How variants are linked to conditions
Pathogenic variants in the KRT14 gene are best known for causing epidermolysis bullosa simplex, so KRT14 gene variants linked to epidermolysis bullosa simplex are the main finding doctors look for. This condition can lead to skin blistering after everyday rubbing, such as from shoes or clothing. Other variants in the KRT14 gene are linked to rare inherited pigment conditions, including Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For disease-causing changes in the KRT14 gene, the chance of developing the related skin condition is mostly set by the variant itself. Heat, friction, and repeated rubbing can make symptoms like blistering worse, but there is not enough evidence that lifestyle changes lower the inherited risk itself.
Inheritance of KRT14 variants
The KRT14 inheritance pattern can differ depending on the specific condition and variant involved. Many KRT14-related skin conditions are inherited in an autosomal dominant way, which means a child can inherit the variant from one affected parent, with a 50% chance in each pregnancy. Some KRT14-related conditions, including certain forms linked to more complete loss of gene activity, follow an autosomal recessive pattern, so a child must inherit one variant from each parent. Because the KRT14 gene is on chromosome 17, it is inherited equally by people of any sex.
What does my KRT14 result mean for my family?
KRT14 results can have different family implications depending on the condition linked to the variant. Many KRT14-related skin conditions are passed down in a dominant way, so close relatives such as a parent, sibling, or child may also carry the same variant and may want to discuss testing. Some KRT14-related epidermolysis bullosa can be recessive, which means relatives may be healthy carriers even if they do not have symptoms.
Genetic information
Genetic testing
How you find out about variants
To look for inherited skin fragility linked to the KRT14 gene, clinicians use KRT14 genetic testing. A lab reads DNA from a blood sample, saliva, or cheek swab and checks the KRT14 gene for variants. Results may identify a disease causing variant, find no relevant change, or show a variant of uncertain significance.
When should I consider getting a genetic test?
Consider KRT14 testing if you or your child has repeated skin blistering from minor rubbing, especially starting at birth or early childhood, or if this runs in your family. Testing can help confirm a skin-blistering condition called epidermolysis bullosa simplex and clarify the chance of it affecting other relatives.
A genetic result is only one part of your health story
A genetic finding can provide useful information, but what it can tell you varies based on the condition and the type of variant involved. Lifestyle, environment, age, and medical history are among the many factors that shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help explain individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people taking the same treatment may not get the same result because their bodies can absorb, break down, or respond to a drug in different ways. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects. Medication response also depends on other factors, including age, liver and kidney function, and other medicines being taken.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that focuses on how differences in genes affect responses to medicines. It examines relationships between genes and drugs to better understand why the same treatment works differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This knowledge can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the KRT14 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so general medication questions are best discussed with your doctor. Seek medical advice if you have side effects, new symptoms, or concerns that a treatment is not helping.
History
The KRT14 gene became historically important when studies of inherited skin blistering helped connect visible family patterns to a specific genetic cause. First described in the scientific literature as part of early genetics, this work grew out of research on keratins in the 1980s and early 1990s. A major step came when pathogenic variants in the KRT14 gene were identified in some people with epidermolysis bullosa simplex, a condition that can cause skin to blister after minor friction. This was one of the clearest early examples showing that changes in structural skin proteins could lead directly to inherited disease. From these first observations, research expanded steadily. The findings helped shape modern skin genetics and improved classification of several inherited blistering conditions.